Highlights
NASDAQ: BLCM       Bellicum Pharma Comm
Last Price Today's Change   Day's Range   Trading Volume
0.844   -0.039 (4.42%)  0.81 - 0.88  374,400

Overview

 
Avg Volume (4 weeks):836,310
4 Weeks Range:0.721 - 1.47
4 Weeks Price Volatility (%):
16.42%
52 Weeks Range:0.721 - 5.44
52 Weeks Price Volatility (%):
2.61%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company. Its research areas are cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases. The company’s expertise is based on the inclusion of powerful molecular switches planned to eliminate, reduce, or activate therapeutic cells to increase efficacy and safety compared with existing cell therapies. Its pipeline portfolio includes adjunct T-cell therapy (BPX-501) to treat leukemias, lymphomas, and genetic blood diseases; CAR T cells technology (BPX-601) to treat prostate, pancreatic, bladder, esophagus, and gastric cancers; and T cell receptors (BPX-701) to treat blood cancers and solid tumors.

  Be the first to like this.
 


 

2601  3059  393  2926 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.644-0.057 
 AMD 39.88+1.32 
 ACB 2.28-0.45 
 I 8.03-5.38 
 AABA 19.630.00 
 F 8.950.00 
 GE 11.44-0.08 
 UBER 26.75-0.04 
 AMRN 22.60-1.42 
 SNAP 14.69+0.75 
Partners & Brokers